U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07024589) titled 'First-in-Human Trial of Oral AN2-502998' on May 31.
Brief Summary: First-in-Human Phase 1, Single-Center, Randomized, Blinded, Placebo-Controlled Trial in Healthy Adults to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Oral AN2-502998
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: AN2-502998
Oral Capsule
DRUG: Placebo
Oral Capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AN2 Therapeutics, Inc
Published by HT Digital Content Services with permission from Health Daily Digest....